Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02135692 |
|---|---|
| Brief Title: | A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects |
| First Submitted : | May 8, 2014 |
| First Submitted that Met QC Criteria : | May 8, 2014 |
| First Posted : | May 12, 2014 (Estimate) |
| Results First Submitted : | March 29, 2018 |
| Results First Submitted that Met QC Criteria : | March 29, 2018 |
| Results First Posted : | May 2, 2018 |
| Last Update Submitted that Met QC Criteria : | November 19, 2019 |
| Last Update Posted : | December 3, 2019 |